Tech Company Financing Transactions
SonoVascular Funding Round
Harbright Ventures and private investors participated in a $6 million Series A venture round for SonoVascular. The round was announced on 2/4/2026.
Transaction Overview
Company Name
Announced On
2/4/2026
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Series A
Investors
Harbright Ventures (Lead Investor)
Proceeds Purpose
The company intends to use the funds to achieve two important milestones during 2026: (i) secure FDA approval for a U.S. based Peripheral Venous pivotal study; and (ii) conduct a FIH study for Pulmonary Embolism treatment.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
101 Glen Lennox Drive 250
Chapel Hill, NC 27517
US
Chapel Hill, NC 27517
US
Phone
Undisclosed
Website
Email Address
Overview
SonoVascular is advancing the SonoThrombectomy System, which is a ultrasound facilitated, thrombolytic enhanced thrombectomy system capable of treating venous and arterial thrombosis, using microbubble-mediated cavitation as a core enabling mechanical mechanism of action to more safely and effectively treat VTE. It is a cathlab-based solution designed to optimize the reduction of clot burden, eliminate blood loss and vascular trauma, and harness the benefit of low dose/duration thrombolytic without bleeding risks.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel Estay
Chief Operating Officer
Luke Harada
VP - Engineering
Jacob Ruprecht
Browse more venture capital transactions:
Prev: 2/3/2026: Arbor venture capital transaction
Next: 2/4/2026: Spectee venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs